Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.

Murray B Resnick1, Mariuxi Gavilanez, Eric Newton

  • 1Department of Pathology, Rhode Island Hospital and Brown University School of Medicine, Providence, RI 02903, USA. mresnick@lifespan.org

Human Pathology
|August 23, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World Practice.

Alimentary pharmacology & therapeutics·2026
Same author

Prediction of OncotypeDX recurrence score using hematoxylin and eosin-stained whole slide images.

NPJ breast cancer·2026
Same author

TTF-1 Is a Sensitive and Specific Immunohistochemical Marker for Autoimmune Gastritis.

The American journal of surgical pathology·2026
Same author

A Strong Correlation Between Pleural Fluid and Serum C-Reactive Protein Levels Across a Spectrum of Pleural Effusions.

Journal of clinical medicine research·2026
Same author

Rapid, intense pericholedochal fibrosis after preoperative biliary drainage: A prospective histologic study in pancreatoduodenectomy specimens.

Annals of hepato-biliary-pancreatic surgery·2026
Same author

Investigation of the Prevalence of Associated Genetic Mutations (Co-Mutations) in Patients with Actionable Driver Mutations in Lung Cancer: A Retrospective Study.

Diagnostics (Basel, Switzerland)·2026

Claudins and ZO-1 are key proteins in gastric cancer. Their expression differs between intestinal and diffuse subtypes, with claudin 4 linked to poorer survival, suggesting biomarker potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Claudins are integral membrane proteins crucial for tight junction formation.
  • Altered claudin expression is implicated in various malignancies.
  • Gastric cancer exhibits distinct histological subtypes with differing prognoses.

Purpose of the Study:

  • To investigate the expression patterns of claudins 1, 3, and 4, and ZO-1 in gastric adenocarcinomas.
  • To correlate these protein expressions with clinicopathologic and prognostic factors in a US patient cohort.
  • To evaluate the potential of claudins as diagnostic biomarkers and therapeutic targets in gastric cancer.

Main Methods:

  • Tissue microarrays from 146 gastric adenocarcinoma patients (intestinal and diffuse subtypes) and adjacent normal mucosa.

Related Experiment Videos

  • Immunohistochemical staining for claudins 1, 3, 4, and ZO-1.
  • Quantitative assessment of staining intensity and correlation with clinicopathologic and survival data using Cox multivariate analysis.

    • Main Results:

    • Claudins 1, 3, 4, and ZO-1 showed differential expression between intestinal and diffuse gastric adenocarcinomas.
    • Higher expression of these proteins was observed in the intestinal subtype compared to the diffuse subtype.
    • Moderate to strong claudin 4 expression was significantly associated with decreased patient survival (P < .02).

    Conclusions:

    • Claudins 1, 3, 4, and ZO-1 are differentially expressed in gastric cancer subtypes, being more prevalent in intestinal-type adenocarcinomas.
    • Claudin 4 up-regulation correlates with poorer prognosis, highlighting its potential as a prognostic biomarker.
    • These findings suggest claudins may serve as valuable diagnostic markers and therapeutic targets in gastric cancer management.